15 November 2016, Madrid, Spain
GaBI organized the ROUNDTABLE ON BIOSIMILARS – Pharmacovigilance, Traceability, Immunogenicity on 15 November 2016, Madrid, Spain in collaboration with the Universidad de Alcalá.
The Roundtable on Biosimilars is an interactive meeting with the participation of academics, regulators, medical practitioners/specialists (oncologists and rheumatologists who are key opinion leaders) and pharmacologists/ pharmacists from Spain, to discuss and exchange information with experts from The Netherlands, Spain and the UK on biosimilars focusing on the key issues of pharmacovigilance, traceability, immunogenicity. Thirty-six participants, speakers included, attended the meeting.
The meeting focused on practical challenges in the implementation of robust pharmacovigilance systems, how to establish pharmacovigilance schemes to enhance traceability and post-marketing surveillance of biologicals including biosimilars, and to promote a dialogue between clinicians, pharmacologists, pharmacists, academics and regulators.
A meeting report of this event has been published in GaBI Journal.
You can download the speakers’ presentations of this roundtable meeting:
Contact us for further information.